YouTube for Information on Rifampicin in Tuberculosis Management: An Analysis of Reliability and Usefulness
Abstract
Tuberculosis (TB) is one of the leading infectious diseases worldwide caused by Mycobacterium tuberculosis. Rifampicin is primarily used as a first-line treatment for TB. There were numerous videos pertaining to the use of rifampicin in the management of TB in YouTube, which were used by students in healthcare studies as their references. The aim of this study is to evaluate the quality and usefulness of the information in YouTube regarding rifampicin in TB management. A systematic search for videos on the YouTube website was conducted using the keywords "Rifampicin" and "Pharmacology of rifampicin". The videos meeting eligibility criteria were assessed. The videos were assessed using a five-question DISCERN scale and Global Quality Score (GQS). Other video characteristics like source/ownership of the videos, duration, views, likes, number of days posted, likeability and comments were also obtained. A total of six videos were selected. Most videos categorised under education as these videos were uploaded by university (n=4; 66.7%). The interquartile range of the GQS was 3 [2.25-3.75], and DISCERN score was 3 [2.25-3.75]. The score from both scales identified that YouTube is a reliable source of references for students to gain deeper understanding about the use of rifampicin in TB management.
Downloads
References
Alsayed, S. S. R., & Gunosewoyo, H. (2023). Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets. International Journal of Molecular Sciences, 24(6). https://doi.org/10.3390/ijms24065202
Aurlene, N., Shaik, S. S., Dickson-Swift, V., & Tadakamadla, S. K. (2024). Assessment of usefulness and reliability of YouTubeTM videos on denture care. International Journal of Dental Hygiene, 22(1), 106–115. https://doi.org/10.1111/idh.12771
Bernard, A., Langille, M., Hughes, S., Rose, C., Leddin, D., & van Zanten, S. V. (2007). A Systematic Review of Patient Inflammatory Bowel Disease Information Resources on the World Wide Web. Official Journal of the American College of Gastroenterology | ACG, 102(9). https://journals.lww.com/ajg/fulltext/2007/09000/a_systematic_review_of_patient_inflammatory_bowel.34.aspx
Charnock, D., Shepperd, S., Needham, G., & Gann, R. (1999). DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. Journal of epidemiology and community health, 53(2), 105–111. https://doi.org/10.1136/jech.53.2.105
Davidson, J., Liebald, B., Liu, J., Nandy, P., Van Vleet, T., Gargi, U., Gupta, S., He, Y., Lambert, M., & Livingston, B. (2010). The YouTube video recommendation system. Proceedings of the Fourth ACM Conference on Recommender Systems, 293–296.
Francesca, C., H., D. A., Nosipho, N., Pauline, H., Daniel, E., M., C. A., M., M. C., Erica, E., Joanna, M., Juliano, T., D., M. T., H., W. G., Anna, B., Robert, H., Christo, V. N., Mengchun, L., Morounfolu, O., & Melvin, S. (2020). Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. New England Journal of Medicine, 382(10), 893–902. https://doi.org/10.1056/NEJMoa1901814
Grobbelaar, M., Louw, G. E., Sampson, S. L., van Helden, P. D., Donald, P. R., & Warren, R. M. (2019). Evolution of rifampicin treatment for tuberculosis. Infection, Genetics and Evolution, 74(April), 103937. https://doi.org/10.1016/j.meegid.2019.103937
Howard, P., Twycross, R., Grove, G., Charlesworth, S., Mihalyo, M., & Wilcock, A. (2015). Rifampin (INN Rifampicin). Journal of Pain and Symptom Management, 50(6), 891–895. https://doi.org/10.1016/j.jpainsymman.2015.09.004
Kaufmann, S. H. E., & Schaible, U. E. (2005). 100th anniversary of Robert Koch’s Nobel Prize for the discovery of the tubercle bacillus. Trends in Microbiology, 13(10), 469–475. https://doi.org/https://doi.org/10.1016/j.tim.2005.08.003
Komrower, D., & Thillai, M. (2015). Tuberculosis and HIV co-infection. Clinical Tuberculosis: A Practical Handbook, 157–170. https://doi.org/10.1201/b20755-13
Ministry of Health Malaysia. (2021). Management of Tuberculosis (Fourth Edition). https://www.moh.gov.my/moh/resources/Penerbitan/CPG/Respiratory/CPG-_Management_of_Tuberculosis_(4th_Edition).pdf
Myungsun, L., Jongseok, L., W., C. M., Hongjo, C., Seonyeong, M., Taeksun, S., E., V. L., C., G. L., Eunhwa, K., Boyoung, J., Hyeeun, P., Hyunkyung, K., Hyunchul, K., Han-Seung, J., Ina, J., Sung, J. J., Y., C. R., N., O. K., A., S. P., … E., B. C. (2024). Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis. New England Journal of Medicine, 367(16), 1508–1518. https://doi.org/10.1056/NEJMoa1201964
Sharma, T., & Sharma, S. (2021). A study of YouTube as an effective educational tool. Journal of Contemporary Issues in Business and Government, 27(1), 2021. https://cibg.org.au/2686
Singh, A. G., Singh, S., & Singh, P. P. (2012). YouTube for information on rheumatoid arthritis - A wakeup call? Journal of Rheumatology, 39(5), 899–903. https://doi.org/10.3899/jrheum.111114
World Health Organization. (2023). Global Tuberculosis Report 2023. https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2023
Yang, L., Qiu, X., Zhao, Q., Qiu, H., Cheng, Y., Liu, W., & Xie, R. (2022). YouTube as a platform to better understand the treatment of lymphoma using ibrutinib: a cross-sectional study. Annals of Translational Medicine, 10(16), 867–867. https://doi.org/10.21037/atm-22-3577
